Search
Menu
Deposition Sciences Inc. - Difficult Coatings - LB - 8/23

Genetix

Facebook X LinkedIn Email
Imaging and image analysis solutions provider Genetix of New Milton, UK, has received US patent No. 7,776,584, aspects of which have been incorporated into the company’s ClonePix FL, a system used for screening and selection of cell lines producing biopharmaceuticals. Significantly reducing the time and cost associated with recombinant protein generation, the system has been validated for the specific detection of secreted antibodies as well as monomeric, cell surface and intrinsic GFP fusion proteins.
LPC/Photonics.com - Newest Webinars on Demand

Published: October 2010
antibodiesbiopharmaceuticalsBiophotonicsBusinesscell surfaceClonePix FLenergyGenetixImage AnalysisImaginginstrinsic GFP fusion proteinsmonomericpatentRapidScanrecombinant proteins generationscreeningselection of cell linesUK

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.